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We transfected naked HGF plasmid DNA into cultured cardiomyocytes using a sonoporation method consisting of ultrasound-
triggered bubble liposome destruction. We examined the eﬀects on transfection eﬃciency of three concentrations of bubble
liposome (1 × 106,1× 107,1× 108/mL), three concentrations of HGF DNA (60, 120, 180μg/mL), two insoniﬁcation times (30,
60sec),andthreeincubationtimes(15,60,120min).Wefoundthatlowconcentrationsofbubbleliposomeandlowconcentrations
ofDNAprovided thelargestamountoftheHGFproteinexpressionbythesonoporatedcardiomyocytes.Variationofinsoniﬁcation
and incubation times did not aﬀect the amount of product. Following insoniﬁcation, cardiomyocytes showed cellular injury, as
determined by a dye exclusion test. The extent of injury was most severe with the highest concentration of bubble liposome. In
conclusion, there are some trade-oﬀs between gene transfection eﬃciency and cellular injury using ultrasound-triggered bubble
liposome destruction as a method for gene transfection.
1.Introduction
Ultrasound-triggered bubble liposome destruction (sono-
poration) has been proposed as a safe nonviral means of
gene therapy that can target many diﬀerent cells or tissues.
In the ﬁeld of cardiovascular medicine, this method may
have signiﬁcant potential for the introduction of therapeutic
genes directly into vascular cells or cardiomyocytes [1, 2].
Sonoporation can only be clinically eﬀective if the dose-
eﬀect relationship between the amount of bubble liposome
and transfection eﬃciency is ﬁrst established. However, few
reports have already examined this dose-eﬀect relationship
and the safety of the procedure [3].
Transfection eﬃciency in sonoporation depends on
various conditions including type of microbubble, mode of
ultrasound, frequency of ultrasound, intensity of acoustic
pressure, concentration of microbubble, dose of DNA,
duration of insoniﬁcation, incubation time of cell with
DNA, repeat count of insoniﬁcation, type of targeted cell,
and other physicochemical conditions like temperature and
carbon dioxide concentration, [3]. Greenleaf et al. reported
that ultrasound acoustic pressure, DNA concentration, and2 Journal of Drug Delivery
repeat count of insoniﬁcation correlated with transfection
rate [4]. Teupe et al. demonstrated that duration of insoni-
ﬁcation did not aﬀect transfection rate [5]. Then, Chen et
al. showed that transfection rate reached plateau when DNA
concentration was increased [6].
Greenleaf et al. also showed that transfection rate peaked
and fell oﬀ according to the change in liposome concen-
tration [4]. They thought it might be derived from cellular
toxicity of large amount of liposome. Li et al. reported
that cell viability decreased along with the increase in
microbubbleconcentration[1].Guoetal. demonstrated that
cell viability decreased with the increase in duration of
insoniﬁcation [7]. Suzuki et al. and Li et al. showed that cell
viability decreased with the increase in ultrasound acoustic
pressure [8, 9].
On the basis of those previous ﬁndings, we planned to
examine the eﬀects of amount of plasmid DNA, liposome
concentration, duration of insoniﬁcation, repeat count of
insoniﬁcation, and time of incubation with liposome, cell,
andDNAontransfectionrate,whichwasmeasuredbymeans
of HGF protein release into culture medium.
2.Materialsand Methods
2.1. Cell Culture. Primary cultures of neonatal ventricular
myocyteswere prepared as described previously [10]. Brieﬂy,
apical halves of cardiac ventricles from 1-day-old Wistar
rats were separated, minced, and dispersed with 0.1% col-
lagenase type II (Worthington Biochemical Corp., Freehold,
NJ). Myocytes were segregated from nonmyocytes using a
discontinuousPercollgradient(SigmaChemicalCo.,Inc.,St.
Louis,MO).Aftercentrifugation,theupperlayerconsistedof
a mixed population of nonmyocyte cell types and the lower
layer consisted almost exclusively of cardiac myocytes. After
the myocytes had been incubated twice on uncoated 10-
cm culture dishes for 30 minutes to remove any remaining
nonmyocytes, the nonattached viable cells were plated on
gelatin-coated 24-well culture plates or 10-cm culture dishes
and then cultured in DMEM (Life Technologies, Grand
Island, NY) supplemented with 10% FCS (Life Technologies,
Grand Island, NY). After 24-hour incubation in DMEM
with FCS, the culture medium was changed to serum-free
DMEM, and all experiments were performed 24 hours later.
This puriﬁcation procedure has well been established [11,
12], and >95% of the cells obtained by this method were
cardiomyocytes.
2.2.Plasmid DNA. Preparation of rat hepatocytegrowth fac-
tor(HGF)expressionplasmidDNAwasdescribedpreviously
[13]. Brieﬂy, rat HGF cDNA cloned by polymerase chain
reaction was inserted into the unique Xho I site between
the cytomegalovirus immediate-early enhancer-chicken β-
actin hybrid promoter and rabbit β-globin poly A site
of the pCAGGS expression plasmid [14]. The resulting
plasmid, pCAGGS-HGF, was grown in Escherichia coli
DH5α (Figure 1(a)). The plasmid was puriﬁed with a
QUIAGEN plasmid DNA kit and dissolved in TE buﬀer. The
puriﬁed plasmid DNA was stored at −20◦Ca n dd i l u t e dt o
the required concentration with distilled water immediately
before use.
2.3. Bubble Liposome. Liposome microbubble, SHU 508A,
consists of palmitic acid and galactose and provides
echogenic micron-sized air bubbles when suspended in
water. The diameter of bubbles ranges from 2 to 8μm, and
97% are smaller than 6μm[ 15]. These air bubbles are
stabilized by palmitic acid, which forms a molecular ﬁlm
that lowers the surface tension of the aqueous vehicle.
The SHU 508A bubbles are nontoxic, have a neutral pH,
are biodegradable, and are made from a physiologically
occurring substance. The physiochemical properties of SHU
508A bubbles are typical of a saccharide solution [15].
2.4. Experiment on Ultrasound Mode. Before performing
the experiments for dose-eﬀect relationships using liposome
sonoporation, we needed to determine the most appropri-
ate ultrasound mode for the sonoporation procedure for
eﬃcient transfection. We tested four modes of ultrasound:
pulsed wave Doppler, color ﬂow Doppler, continuous wave
Doppler, and harmonic power Doppler, which are available
with standard echocardiographic machinery in a clinical lab-
oratory. We performed a simple transfection experiment at
t h es a m ea c o u s t i cp r e s s u r eo f0 . 5W / c m 2 for each ultrasound
mode, using a single condition with 60μgH G Fp l a s m i d
DNA, 1 × 107 particles/mL of SHU 508A liposome, 30sec
insoniﬁcation, 15min of DNA incubation, and 3 repetitions
of insoniﬁcation.
Rat neonatal cardiomyocytes were inoculated and grown
to conﬂuence in DMEM+10% FCS. After conﬂuence had
beenreachedina35mmPetridish,themediumwaschanged
to fresh deﬁned serum-free medium. Plasmid DNA was
diluted with distilled water immediately before the transfec-
tion. Each experiment was performed on 20 dishes. Cells on
each dish were treated with ultrasound (Figure 1(b)). Pulsed
wave Doppler, color ﬂow Doppler, and continuous wave
Dopplerwere insoniﬁed from PSK-25ATacoustictransducer
with Toshiba SSA-380A (Toshiba Medical Systems), and
harmonic power Doppler was insoniﬁed from S3 transducer
with Sonos 5500 (Phillips Medical Systems). The exper-
imental results are shown in Figure 2. Continuous-wave
Doppler ultrasound was the most eﬃcacious and was used
for subsequent experiments.
2.5. Experiments for Dose-Eﬀect Relations. The medium
in 35mm Petri dishes containing the cardiomyocytes
was changed to fresh deﬁned serum-free medium from
DMEM+10% FCS. Rat HGF plasmid DNA was diluted with
distilled water, and a volume corresponding to 60, 120, or
180μgwasaddedtoeachofthe20PetridishesperDNAdose.
Cells on each dish were then treated with continuous-wave
Doppler ultrasound (frequency of 2.5MHz and acoustic
intensity of 0.5W/cm2 from a PSK-25ATacoustic transducer
with Toshiba SSA-380A Ultrasound system) with SHU 508A
liposome (1 × 107 particles/mL) for acoustic exposure time
of 30 or 60 seconds at room temperature (Figure 1(b)).
In a separate series of experiments, we tested four liposomeJournal of Drug Delivery 3
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Figure 1: (a) Structure of the expression plasmid pCAGGS-HGF. The expression cassette of pCAGGS-HGF contains chicken β-actin
promoter, rat HGF, and rabbit β-globin poly A. (b) Experimental setup. The transducer was attached to the bottom of the dish.
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Figure 2: Comparison of four modes of ultrasound for sono-
poration. Cells treated with continuous-wave Doppler ultrasound
yielded the largest amount of HGF protein indicating this to be the
most eﬀective ultrasound mode. CFD: color ﬂow Doppler; PWD:
pulsed wave Doppler; CWD: continuous wave Doppler; Harmonic:
harmonic power Doppler. ∗P<. 05 versus DNA alone; ∗∗P<. 05
versus CFD; ∗∗∗P<. 05 versus PWD; †P<. 05 versus Harmonic.
concentrations (0, 1 × 106,1× 107 or 1 × 108 particles/mL),
three insoniﬁcation repetitions (1 insoniﬁcation only, 3 or 5
insoniﬁcations for 30 seconds), and three DNA incubation
times (15, 60 or 120min). After the incubation, the culture
medium was changed to normal DMEM+10% FCS and
the cells were cultured for 72 hours. In a separate set
of experiments, we examined the eﬀect of culture period
on the amount of DNA product that is HGF protein by
discontinuing culture at 24, 48, and 72 hours and measuring
the amount of rat HGF protein in the medium. The total
amountofproteincontentintheculturedcellswasmeasured
and used to correct the HGF level in each dish. We measured
rat HGF protein using an EIA kit (Institute of Immunology
Co., Ltd., Tokyo, Japan) [13] and protein content of cultured
cells using a Modiﬁed Lowry Protein Assay Kit (Pierce
Biotechnology, Rockford).
2.6. Viability of Cultured Cells. To determine the safety
of sonoporation, in a separate experiment, cultured cells
were exposed to 0.1% trypan blue for 5min just after
ultrasound insoniﬁcation. This allowed assessment of sar-
colemmal membrane damage and was performed for each
concentration of liposome, each insoniﬁcation time, and
each number of repetitions of insoniﬁcation. The number
of stained and unstained cells in the dishes was counted
and used to calculate the percentage of intact cells [16].
The degree of cellular injury caused by sonoporation was
determined by examining the insoniﬁed cells by scanning
electron microscopy (Hitachi S-4800). Immediately after
ultrasound insoniﬁcation in the presence of liposome, the
cardiomyocytes were ﬁxed with phosphate-buﬀered 2.5%
glutaraldehydefor 4 hours, followed by postﬁxation with 1%4 Journal of Drug Delivery
osmium tetroxide for 1 hour, and then were conventionally
prepared for scanning electron microscopy.
2.7. Statistical Analysis. Data were expressed as the mean ±
SEM. Comparisons of parameters from experimental groups
were performed with unpaired t tests and resulting P-
values were corrected according to the Bonferroni method.
In analyses, P<. 05 was considered to indicate statistical
signiﬁcance.
3.Results
3.1. Eﬀect of Culture Period on HGF Protein Production by
Sonoporated Cardiomyocytes. The concentration of HGF
proteinintheculturemediumincreasedasthecultureperiod
after ultrasonic transfection was extended. The transfection
consisted ofthree 30-sec insoniﬁcations a 15-min incubation
with HGF DNA (60μg) and liposome (1 × 107 particle/mL)
(Figure3(a)).After72hoursofculture,HGFproteinconcen-
tration in the culture medium was measured and corrected
using the protein content of the cultured cells.
3.2.Eﬀect oftheAmountofPlasmid DNA onHGFProteinPro-
duction by Sonoporated Cardiomyocytes. HGF protein con-
centrationintheculturemediumwas0.54±0.049ng/mL/mg
and was highest when 60μg of DNA was administered with
a liposome concentration of 1 × 107 particles/mL, a15-min
incubation, and three 30-sec insoniﬁcation. Although the
nominal mean values of HGF protein after transfection of
120and 180μg DNA were lower than those after transfection
of 60μg, the diﬀerences were not statistically signiﬁcant
(Figure 3(b)).
3.3. Eﬀect of Incubation Period with Plasmid DNA and Lipo-
some on HGF Protein Production by Sonoporated Cardiomy-
ocytes. HGF protein concentration in the culture medium
was 0.56 ± 0.053ng/mL/mg and was highest when the
incubation time was 15min with a liposome concentration
of 1 × 107 particles/mL, 60μg DNA, and three 30-sec
insoniﬁcation. Although the mean values of HGF protein
after transfection for 60 and 120min were lower than those
after 15min incubation, the diﬀerences were not statistically
signiﬁcant (Figure 3(c)).
3.4. Eﬀect of Insoniﬁcation Time on HGF Protein Production
by Sonoporated Cardiomyocytes. HGF protein concentration
in the culture medium was 0.59 ± 0.052ng/mL/mg and was
highest when the insoniﬁcation period was 30sec with 60μg
DNA, a liposome concentration of 1 × 107 particles/mL,
and 15-min incubation. There was no signiﬁcant diﬀerence
in HGF production in cells insoniﬁed for 30 and 60min
(Figure 3(d)).
3.5. Eﬀect of Liposome Concentration on HGF Protein Produc-
tion by Sonoporated Cardiomyocytes. HGF protein concen-
tration in the culture medium was 0.53 ± 0.053ng/mL/mg
and was nominally highest when the liposome concentration
was 1 × 107 particles/mL and insoniﬁcation consisted of
three 30-sec ultrasound exposures, though it was statistically
similar tothatobtainedwith 1×106 particles/mL.Atahigher
liposome concentrationof1×108 particles/mL, HGFprotein
concentration decreased (Figure 3(e)).
3.6. Eﬀect of Repetition of Insoniﬁcation on HGF Protein Pro-
duction by Sonoporated Cardiomyocytes. HGF protein con-
centration in the culture medium was 0.54 ± 0.053ng/mL/
mg and was highest when three 30-sec insoniﬁcations were
given, with a liposome concentration of 1×107 particles/mL
and 60mg DNA. This protein production was statisti-
cally higher than in cells given one or ﬁve insoniﬁcations
(Figure 3(f)).
3.7. Eﬀect of Insoniﬁcation Time on Cell Viability. The per-
centage of dead cells was 14.7 ± 0.9% and was higher in the
cells given ﬁve 30-sec insoniﬁcations at a liposome concen-
tration of 1 × 107 particles/mL (Figure 4(a)). There was no
statistical diﬀerence between 30- and 60-sec insoniﬁcation.
3.8. Eﬀect of Liposome Concentration on Cell Viability. The
percentage of dead cells increased with increasing concen-
trations of liposome (Figure 4(b)). The dead cell count was
24.8 ± 2.9% and was highest when the liposome concentra-
tionwas1×108 particles/mLand three30-secinsoniﬁcations
were used.
3.9. Eﬀect of Number of Insoniﬁcation Repetitions on Cell Via-
bility. The percentage of dead cells increased as the number
of insoniﬁcation repetitions increased (Figure 4(c)). The
dead cell count was 14.7 ± 0.9% and was highest when
ﬁve repetitions of the insoniﬁcation step were given, with
a liposome concentration of 1 × 107 particles/mL.
3.10. Scanning Electron Microscopy Observations of Sonopo-
rated Cardiomyocytes. No particular changes were evident
on the surfaces of untreated control cultured cardiomyocytes
when viewed with the scanning electron microscope at low
and high magniﬁcation (Figures 5(a) and 5(b)). After sono-
poration with a low concentration of liposome (Figure 5(c))
and with a high concentration of liposome (Figure 5(d)),
microdimples or pores were observed on the surfaces of the
cultured cardiomyocytes.
4.Discussion
Considerable eﬀorts have been made to develop methods
that will allow eﬀective and safe introduction of vectors into
cells for gene therapy. However, we still need a breakthrough
in the form of a novel vector that will transform cells at
high eﬃciency and with low risk of adverse eﬀects. This is
especially true in cardiovascular medicine, where malignant
cellular transformation is rare [17]. One of the promising
candidates for safe and eﬃcacious gene transfection is a
naked plasmid vector that has been modiﬁed to have high
aﬃnity for cardiovascular tissues but which has no built-
in viral components [17, 18]. We have developed a method
for electroporation of a cytokine gene for treatment ofJournal of Drug Delivery 5
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Figure3:(a)Eﬀect ofculture periodaftertransfectionofHGFDNA onHGFproteinproductionusing60μgofDN Aand1×10
7 particles/mL
liposome with three 30-sec insoniﬁcations and 15-min incubation with DNA. Baseline was the concentration of rat HGF protein in the
culture medium around rat cardiomyocytes without any intervention at the beginning of cell culture. ∗P<. 05 versus baseline; ∗∗P<
.05 versus 24 hours after the onset of culture; ∗∗∗P<. 05 versus 48 hours after the onset of culture. (b) Eﬀect of amount of plasmid
DNA on HGF protein production using 1 × 10
7 particles/mL liposome with three 30-sec insoniﬁcations and 15-min incubation with DNA.
“DNA alone” indicates the concentration of rat HGF protein in the culture medium of cardiomyocytes treated with 60μgD N Aw i t h o u t
insoniﬁcation. ∗P<. 05 versus DNA alone. (c) Eﬀect of incubation period of cardiomyocytes with plasmid DNA and liposome on HGF
protein production using 60μgo fD N Aa n d1× 107 particles/mL liposome with three 30-sec insoniﬁcations. ∗P<. 05 versus DNA alone.
(d) Eﬀect of insoniﬁcation time on protein production using 60μgo fD N A ,1× 107 particles/mL liposome, and 15-min incubation with
DNA, and three 30- or 60-sec insoniﬁcations. ∗P<. 05 versus DNA alone. (e) Eﬀect of liposome concentration on HGF protein production
using 60μg of DNA with three 30-sec insoniﬁcations and 15-min incubation with DNA. ∗P<. 05 versus DNA alone; ∗∗P<. 05 versus 0
particles/mL; ∗∗∗P<. 05 versus 1×10
8 particles/mL. (f) Eﬀect ofrepetition ofinsoniﬁcationon HGF protein production using6μgo fD N A
and 1 × 107 particles/mL liposome with 15-min incubation with DNA. ∗P<. 05 versus DNA alone; ∗∗P<. 05 versus 1 time; ∗∗∗P<. 05
versus 5 times.
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Figure 4: (a) Eﬀect of insoniﬁcation time on cell viability using 60μgo fD N A ,1× 107 particles/mL liposome, and 15-min incubation with
DNA,andthree30-or60-secinsoniﬁcations.“USalone”representsthepercentageofdeadcellsimmediatelyafterthree30-secinsoniﬁcations
in the absence of liposomeand DNA. ∗P<. 05 versus baseline. (b) Eﬀect ofliposome concentrationon cell viability using 60μgo fD N Aa n d
three 30-sec insoniﬁcations and1 5 - m i ni n c u b a t i o nw i t hD N A .∗P<. 05 versus baseline; ∗∗P<. 05 versus 1 × 10
6 particles/mL; ∗∗∗P<. 05
versus 1×108 particles/mL. (c) Eﬀect ofrepetitions ofinsoniﬁcationon cell viabilityusing60μgofD N A ,1×107 particles/mL liposome,and
15-min incubation with DNA. ∗P<. 05 versus baseline; ∗∗P<. 05 versus 30sec × 1.6 Journal of Drug Delivery
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Figure 5: (a) and (b) Scanning electron microscopic images of intact cell surfaces of cultured cardiomyocytes. Scale dots are indicated on
the images. (c) Image of a cell surface immediately after sonoporation using 1 × 106 particles/mL liposome. (d) Image of a cell surface
immediately after sonoporationusing 1 ×108 particles/mL liposome.
cardiomyopathy [13]. However, using electric shock for
transfection is not clinically practical. For this reason, we are
pursuing the present sonoporation method as a protocol for
gene transfection.
The HGF protein used in the present study is found
in a wide variety of cell types and has multiple biological
properties, including mitogenic, motogenic, morphogenic
and antiapoptotic activities [19]. Several lines of evidence
indicate that this molecule has potential for therapeutic use
for treatment of heart failure, myocardial infarction, angina,
and hypertension [20–22]. HGF may also have enormous
therapeutic potential for hepatic and renal disorders, in
addition to cardiovascular diseases [23–26].
In the present study, we showed variations in amount of
HGF plasmid DNA,liposome concentration, the duration of
insoniﬁcation, and incubation time of the cardiomyocytes
with liposome and DNA, and their dose relationships with
the ﬁnal amount of HGF protein released from the cultured
neonatal cardiomyocytes. We found that speciﬁc amounts
of liposome and repetitions of insoniﬁcation were needed
for eﬀective protein production from cardiomyocytes. How-
ever, high concentrations of bubble liposome and large
numbers of repeat insoniﬁcations resulted in decreased cell
viability.
Plasma membrane sonoporation induced by ultrasound
and subsequent self-sealing has been reported in previous
investigations [27–29]. However, the exact mechanism by
which membrane sonoporation causes substance incorpora-
tion into the cell is not yet understood. Some investigators
speculate that the membrane poration results in both trans-
fection eﬃciency and cellular damage. In the present study,
scanning microscopy images revealed some microdimples
or pores on the cell surface after sonoporation, which did
not exist on the surface of control cardiomyocytes. The
numbers of dimples or pores tended to increase with higher
concentrations of liposome. Thus, we speculate that these
dimples or pores on the cell surface might be related to
transfection eﬃciency and might be evidence of cellular
injury by sonoporation. Previous studies of sonoporation of
vascular walls revealed that microbubble destruction would
cause rupture of microvessels and extravasation [30–33],
which would cancel out some beneﬁts of sonoporation.
Thus, the poration and self-sealing mechanism needs to be
fully investigated and optimized.
A sonoporation technique targeting the cardiovascular
system has now been developed for gene transfection to
myocardium, limb skeletal muscle, and arteries [34–37].
For a variety of target tissues, a number of microbubbles,
including liposomes, and a range of ultrasound modes have
been developed. The optimal combination of the type of
microbubble, ultrasound mode, and target tissue still needs
to be resolved [38–40]. However, the principal types of
ultrasound used forsonoporationhaveincludedpulsedwave
Doppler or continuous wave Doppler with acoustic pressure
ranging0.5–5W/cm2 [34–37].Inthepresentstudy,wefound
that continuous wave Doppler at a standard frequency for
clinical use, that is, 2.5MHz and the usual acoustic pressure
of 0.5W/cm2,w a sm o s te ﬀective with our cardiomyocytes.Journal of Drug Delivery 7
T h er e a s o nw eu s e do n eo ft h es t a n d a r du l t r a s o u n dm o d e s
with standard settings for clinical use is that we would like to
use our sonoporation system eventually in a clinical setting.
The present study has several limitations. To avoid the
complexity of numerous combinations of experimental con-
ditions, such as amount of DNA, concentration of liposome,
duration of insoniﬁcation, repeat count of insoniﬁcation,
length of incubation time, and culture period after gene
transfection, we only used several practical combinations for
aninvitroexperimentforculturedcardiomyocytes.Thus,we
might have missed other multimodal aspects of dose-eﬀect
relationships among these conditions.
5.Conclusion
HGF DNA was successfully transferred to cultured car-
diomyocytes using sonoporation with a deﬁned liposome
concentration and a mode of insoniﬁcation. A number of
trade-oﬀs between transfection eﬃciency and cellular injury
have to be balanced to optimize this sonoporation method.
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